The private sector lender Bandhan Bank, which has its headquarters in Kolkata, said in a regulatory filing on January 7 that its total deposits in the third quarter of FY23 exceeded Rs 1 lakh crore. The lender’s total deposits and advances increased by 21 percent, from Rs 84,500 in the same period of the prior
Tata Consultancy Services (TCS), the largest provider of IT services in India, launched the earnings season on Monday by announcing a less-than-expected 11% increase in profit for the December quarter at 10,846 crore. The company’s third quarter earnings was predicted by analysts to be above 11,000 crore, on average. However, the company’s rupee revenue for
JSW Steel reported on Monday that its total combined production of crude steel increased 17% to 6.24 million tonnes (MT) during October and December of 2022–23. 5.35 MT were produced collectively during the same period last year, according to a statement from JSW Steel. “JSW Steel reported its group combined crude steel output at 6.24 million
PVR has added 3 new multiplexes with a combined 19 screens in Jaipur, Bengaluru, and Gurugram. The firm has opened the largest multiplex in Rajasthan, an 8-screen theatre, a 7-screen theatre at the Bhartiya Mall in Bengaluru’s Bhartiya City, and a 4-screen theatre at the Elan Town Centre in Haryana. PVR presently runs the largest
The recently unveiled luxury residential complex TARC Tripundra in Delhi has generated sales of Rs 350 crore for TARC, a real estate developer with headquarters in New Delhi. TARC Tripundra is conveniently located near Pushpanjali Farms on New Delhi’s well-known Bijwasan Road and has easy access to the Aerocity, Cyber City, and Indira Gandhi International
Asian Paints has been given the go-ahead to build a new water-based paint manufacturing facility with an annual production capacity of 4 lakh kiloliters for a cost of about Rs 2,000 crore. After acquiring land, the facility’s manufacturing is anticipated to be operational in three years. The company is looking into the feasibility of making
Lupin announced that the FDA has approved its Abbreviated New Drug Application (ANDA), Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, to market a generic equivalent of Pfizer Inc.’s Toviaz Extended-Release Tablets, 4 mg and 8 mg. Lupin’s facility in Goa, India, will produce the product. In the United States, sales of Fesoterodine Fumarate
According to Hi-Tech Pipes, company has signed a memorandum of understanding with the Uttar Pradesh government to invest Rs 510 crore in the construction of a massive facility for the manufacture of steel tubes and pipes as well as the processing of flat steel. The company added that the UP government’s unique incentive programmes and
Ashoka Buildcon has emerged as the lowest Bidder (L-1) for the National Highway Authority of India (NHAI) for the Project for the construction of Four Lane Elevated Corridor and at-grade improvements beginning with Design Ch: 0+000 up to Design Ch 19+870 of Danapur and Danapur Bihta Section, which will provide connectivity with the current RoB
Alembic Pharmaceuticals (Alembic) announced that it has received final FDA approval for its Abbreviated New Drug Application (ANDA), Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg. The ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pfizer Inc.’s Toviaz Extended-Release Tablets, 4 mg and 8 mg. Fesoterodine Fumarate Extended-Release Tablets are used
